The Relation Between Biofilm Formation and Alginate Production in Pseudomonas aeruginosa; An Important and Neglected Topic

سال انتشار: 1403
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 20

نسخه کامل این مقاله ارائه نشده است و در دسترس نمی باشد

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

JR_IJMM-18-5_005

تاریخ نمایه سازی: 11 دی 1403

چکیده مقاله:

Background and Aims: Pseudomonas aeruginosa (P. aeruginosa) is one of the most common opportunistic bacteria causing healthcare-associated infections (HAIs). Alginate as an adhesion substance plays role in its binding to inanimate surfaces and protecting against environmental conditions. Biofilm also increases the bacterial resistance to antimicrobials and immune system. The present study was aimed to survey the antimicrobial resistance pattern, biofilm formation, and alginate production in the clinical isolates of P. aeruginosa. Materials and Methods: In this cross-sectional study in a period of one year ۹۰ non-duplicative P. aeruginosa were isolated from the clinical samples. Antimicrobial susceptibility testing was performed by disk diffusion method. Biofilm formation and alginate production were measured by microtiter plate and carbazole assay, respectively. Polymerase chain reaction was conducted for detection of pslA, pelA, ppyR, algD, algU and algL genes. Results: The highest resistance rate (۷۴.۴%) was related to ceftazidime. Alginate production was found in ۸۷.۸% of the isolates, which production levels were <۲۵۰ µgml-۱, ۲۵۰-۴۰۰ µgml-۱, and >۴۰۰ µgml-۱ in ۷.۶%, ۵۳.۲%, and ۳۹.۲ of the isolates, respectively. The categories of biofilm formation in strains were as weak (۱۱.۱%), moderate (۲۴.۱%), and strong (۶۴.۸%). The prevalence of ppyR, algD, algU, algL, pslA and pelA genes were ۱۰۰.۰%, ۹۲.۲%, ۸۶.۶%, ۶۷.۷%, ۸۵.۲% and ۴۲.۵%, respectively. Conclusion: The results highlighted an alarming trend in P. aeruginosa strains antibiotic resistance rates. A significant relationship was also observed between the alginate production and the biofilm formation. Thus, periodic monitoring, adherence to the antibiotic stewardship, avoiding arbitrary prescribing, and screening tests are unavoidable.

نویسندگان

Maryam Shafigh

Department of Microbiology, Ayatollah Amoli Branch, Islamic Azad University, Amol, Iran

Rabieh Izadi Amoli

Department of Microbiology, Ayatollah Amoli Branch, Islamic Azad University, Amol, Iran

Abazar Pournajaf

Infectious Disease and Tropical Medicine Research Center, Health Research institute, Babol University of Medical Sciences, Babol, Iran

Yousef Yahyapour

Infectious Disease and Tropical Medicine Research Center, Health Research institute, Babol University of Medical Sciences, Babol, Iran

Hami Kaboosi

Department of Microbiology, Ayatollah Amoli Branch, Islamic Azad University, Amol, Iran

مراجع و منابع این مقاله:

لیست زیر مراجع و منابع استفاده شده در این مقاله را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود مقاله لینک شده اند :
  • Rocha AJ, Barsottini MR, Rocha RR, Laurindo MV, Moraes FL, ...
  • Kaier K, Heister T, Götting T, Wolkewitz M, Mutters NT. ...
  • Ammazzalorso A, Granese A, De Filippis B. Recent trends and ...
  • Fernández-Billón M, Llambías-Cabot AE, Jordana-Lluch E, Oliver A, Macià MD. ...
  • Kothari A, Kherdekar R, Mago V, Uniyal M, Mamgain G, ...
  • Thi MTT, Wibowo D, Rehm BH. Pseudomonas aeruginosa biofilms. Int ...
  • Peng N, Cai P, Mortimer M, Wu Y, Gao C, ...
  • Colvin KM, Irie Y, Tart CS, Urbano R, Whitney JC, ...
  • Colvin KM, Gordon VD, Murakami K, Borlee BR, Wozniak DJ, ...
  • Hentzer M, Teitzel GM, Balzer GJ, Heydorn A, Molin S, ...
  • May TB, Chakrabarty A. Pseudomonas aeruginosa: genes and enzymes of ...
  • Chung J, Eisha S, Park S, Morris AJ, Martin I. ...
  • Blanco-Cabra N, Paetzold B, Ferrar T, Mazzolini R, Torrents E, ...
  • Abidi SH, Sherwani SK, Siddiqui TR, Bashir A, Kazmi SU. ...
  • Ramazani R, Izadi Amoli R, Taghizadeh Armaki M, Pournajaf A, ...
  • Davarzani F, Saidi N, Besharati S, Saderi H, Rasooli I, ...
  • Humphries R, Bobenchik AM, Hindler JA, Schuetz AN. Overview of ...
  • Pournajaf A, Razavi S, Irajian G, Ardebili A, Erfani Y, ...
  • Ramazani R, Izadi Amoli R, Taghizadeh Armaki M, Pournajaf A, ...
  • Karlowsky JA, Wise MG, Hsieh T-C, Lu H-C, Chen W-T, ...
  • Vaez H, Salehi-Abargouei A, Ghalehnoo ZR, Khademi F. Multidrug resistant ...
  • Chapter ۱ - Combination therapy: Current status and future perspectives. ...
  • Lai X, Han M-L, Ding Y, Chow SH, Le Brun ...
  • Ghadaksaz A, Fooladi AAI, Hosseini HM, Amin M. The prevalence ...
  • Valadbeigi H, Sadeghifard N, Rafiei Tabatabaei R, Maleki A. A ...
  • Skariyachan S, Sridhar VS, Packirisamy S, Kumargowda ST, Challapilli SB. ...
  • Elogne CK, N'Guetta A, Yeo A, David C, Guessennd N, ...
  • Rajabi H, Salimizand H, Khodabandehloo M, Fayyazi A, Ramazanzadeh R. ...
  • Hassan A, Usman J, Kaleem F, Omair M, Khalid A, ...
  • https://doi.org/۱۰.۱۰۱۶/S۱۴۱۳-۸۶۷۰(۱۱)۷۰۱۹۷-۰Stepanović S, Vuković D, Hola V, Bonaventura GD, Djukić S, ...
  • Kamali E, Jamali A, Ardebili A, Ezadi F, Mohebbi A. ...
  • Soleymani-Fard Z, Hassanshahian M, Jasim SA, Abdelbasset WK, Shichiyakh RA, ...
  • نمایش کامل مراجع